Lilly partners with nvidia to build the industry's most powerful ai supercomputer, supercharging medicine discovery and delivery for patients

New ai capabilities will help scientists identify, optimize and validate new molecules additional applications include manufacturing, medical imaging and enterprise ai agents indianapolis , oct. 28, 2025 /prnewswire/ -- eli lilly and company (nyse: lly) today announced it is building the most powerful supercomputer owned and operated by a pharmaceutical company, in collaboration with nvidia. the supercomputer will power an "ai factory," a specialized computing infrastructure that manages the entire ai lifecycle from data ingestion and training to fine-tuning and high-volume inference.
NVDA Ratings Summary
NVDA Quant Ranking